CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Sales, net	$ 7,599,363	$ 11,001,102
Cost of sales:
Total cost of sales	5,698,434	8,131,574
Gross profit	1,900,929	2,869,528
Operating expenses:
Sales and marketing	1,434,742	1,350,171
Research and development	142,262	129,757
General and administrative	3,310,062	4,130,023
Total operating expenses	4,887,066	5,609,951
Loss from operations	(2,986,137)	(2,740,423)
Other income - TIA	1,484,620	1,557,779
Unrealized gain on debt and equity securities	1,732,649	1,492,011
Gain on sale of equity securities		746,262
Interest and other income	317,321	209,815
Interest expense	(33,483)	(43,555)
Income before income taxes	514,970	1,221,889
Provision for income taxes	85,586	230,917
Net income	429,384	990,972
Preferred Stock dividend requirements	(57,611)	(58,111)
Net income applicable to common shareholders	$ 371,773	$ 932,861
Basic earnings per share	$ 0.01	$ 0.03
Diluted earnings per share	$ 0.01	$ 0.03
Weighted average common shares outstanding:
Basic (in shares)	29,937,159	29,937,159
Diluted (in shares)	29,945,353	29,963,763
Costs of manufactured product
Cost of sales:
Total cost of sales	$ 5,049,046	$ 7,361,865
Royalty expense to shareholder
Cost of sales:
Total cost of sales	$ 649,388	$ 769,709